Business Update

Miraculins appoints Washington D.C. law firm Hogan & Hartson to consult on U.S. FDA matters

Published in Medical Letter on the CDC and FDA, December 10th, 2006

Miraculins Inc. (MOM), a biotechnology company focused on cancer biomarkers for use in developing diagnostic tools and therapeutic products, announced it has named the law firm Hogan & Hartson, Washington, D.C., to provide legal and strategic advice concerning the U.S. Food and Drug Administration (FDA) approval process for the company's prostate cancer diagnostic product.

Jim Charlton, president of Miraculins, said Miraculins has had initial communication with the FDA, and now appoints Hogan & Hartson in recognition of the advancing state of the company's diagnostic test. Further, the company is now finalizing the preferred sales and distribution strategy for its...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2006-12-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry